Accurate Bioanalytical Peptide Quantification of Salmon Calcitonin Using High Resolution Mass Spectrometry (HRMS)

Importance of the Topic

High-resolution mass spectrometry (HRMS) has emerged as a powerful tool for bioanalytical quantification of peptide therapeutics. As the pharmaceutical industry shifts towards larger biomolecules, sensitive, selective, and high-throughput methods are required to measure low-abundance peptides in complex matrices such as human serum. HRMS platforms offer broad mass range, high accuracy, and the ability to capture both quantitative and qualitative data in a single run, making them well suited for modern peptide bioanalysis.

Study Objectives and Overview

The primary goal of this work was to evaluate the quantitative performance of the Waters Xevo G2-XS QTof Mass Spectrometer for the determination of salmon calcitonin extracted from human serum. Key objectives included:

• Establishing a limit of quantification and linear dynamic range.
• Comparing HRMS results with a conventional tandem quadrupole (Xevo TQ-XS) assay.
• Assessing accuracy, precision, and selectivity using targeted acquisition modes.

Methodology

Salmon calcitonin was spiked into 100 µL of human serum and isolated via mixed-mode solid phase extraction. Chromatographic separation was performed on an ACQUITY UPLC system with a CORTECS UPLC C18+ column (90 Å, 1.6 µm, 2.1 × 50 mm) using a 4.5-minute gradient (5–75% acetonitrile in 0.1% formic acid) at 0.4 mL/min.

Quantitative analysis on the Xevo G2-XS QTof was conducted in targeted ToF MRM (Precursor → Precursor) mode with Target Enhancement, monitoring both the 4+ (859.146 m/z) and 5+ (687.911 m/z) precursors using narrow mass extraction windows (down to 20 mDa). Data were benchmarked against conventional MRM (Precursor → Product) on the Xevo TQ-XS Tandem Quadrupole under comparable conditions.

Used Instrumentation

• Waters Xevo G2-XS QTof Mass Spectrometer
• Waters Xevo TQ-XS Tandem Quadrupole Mass Spectrometer
• Waters ACQUITY UPLC System
• CORTECS UPLC C18+ Column (90 Å, 1.6 µm, 2.1 × 50 mm)

Main Results and Discussion

The Xevo G2-XS QTof method achieved a lower limit of quantification (LLOQ) of 50 pg/mL, with a linear range of 50–1,500 pg/mL (R² > 0.99, 1/x weighting). Accuracy across calibration points was within 85–110%, and intra- and inter-run precision yielded CVs below 10%. Narrow mass extraction windows (20 mDa) significantly improved signal-to-noise (S/N = 27 at 500 pg/mL) by eliminating endogenous interferences. Comparative analysis showed HRMS quantification within two-fold of the Xevo TQ-XS performance while offering enhanced selectivity.

Benefits and Practical Applications of the Method

By combining simple sample preparation, rapid UPLC separation, and targeted HRMS detection, this workflow delivers robust, high-throughput peptide quantification with minimal sample volume. The dual capability to record qualitative and quantitative information in a single experiment streamlines assay development, supports regulatory compliance, and enhances confidence in pharmacokinetic and biomarker studies.

Future Trends and Opportunities

Advancements in HRMS resolution, acquisition speed, and data processing algorithms will continue to expand its role in multi-attribute monitoring of biotherapeutics. Emerging mixed-mode SPE formats and microflow chromatography are expected to further reduce sample requirements and improve throughput. Integration of HRMS with ion mobility and real-time informatics will open new avenues for deeper characterization of peptide modifications and metabolites.

Conclusion

This study demonstrates that the Xevo G2-XS QTof Mass Spectrometer delivers sensitive, accurate, and precise quantification of salmon calcitonin in human serum, matching the performance of a state-of-the-art tandem quadrupole platform while providing enhanced selectivity and qualitative insights. The approach is readily transferable to other therapeutic peptides and complex biological matrices.

Reference

• Mary Lame and Nikunj Tanna, Accurate Bioanalytical Peptide Quantification of Salmon Calcitonin Using High Resolution Mass Spectrometry (HRMS), Waters Corporation, Milford, MA, USA, 2018.
• Waters Application Note 720006342EN: Bioanalytical Quantification of Salmon Calcitonin from Serum Using Mixed-Mode SPE and HRMS, Waters Corporation.